跳至主要内容
临床试验/NCT04367428
NCT04367428Unknown3 期

Effects of Pre- and Postoperative Probiotics Administration on Postoperative Weight Loss in Patients Undergoing Sleeve Gastrectomy

Hospital General Universitario Elche0 个研究点目标入组 60 人开始时间: 2020年5月2日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
60
主要终点
Weight loss

研究概览

简要总结

Patients will be randomized into 2 groups:

  • G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics
  • G2: Patients undergoing sleeve gastrectomy as bariatric procedure and not receiving pre- or postoperative probiotics

Weight loss will be assessed 1 year after surgery

详细描述

Patients will be randomized into 2 groups:

  • G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics
  • G2: Patients undergoing sleeve gastrectomy as bariatric procedure and not receiving pre- or postoperative probiotics

Preoperative probiotics scheme include:

  • saccharomyces boulardii ntc 5375 + enterococcus faecium UBEF-41 + lactobacillus acidophilus LA 14 during 15 days (between 6th and 4th weeks before surgery)
  • Bifidobacterium lactis BL 04 + Bifidobacterium breve BB 03 + Bifidobacterium bifidum BB 06 + Bifidobacterium longum BL 05 during 15 days (between 4th and 2nd weeks before surgery)
  • lactobacillus rhamnosus LR 32 + lactobacillus rhamnosus HN001 + lactobacillus acidophillus LA 14 during 15 days (between 2nd week and the day before surgery)

Postoperative probiotics scheme include:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI >35 associated to diabetes mellitus, hypertension, dyslipidemia or sleep apnea/hypopnea síndrome
  • Patients undergoing laparoscopic sleeve gastrectomy as primary bariatric procedure

排除标准

  • Revisional surgery
  • Patients with gastroesophageal reflux disease
  • Patients planned for a sleeve gastrectomy as first step of a second malabsorptive procedure
  • Patients with immune deficiencies or with chronic intake of immune supressor drugs
  • patients refusing to participate in the study

结局指标

主要结局

Weight loss

时间窗: 1 year after surgery

Weight loss will be assessed as excess body mass index (BMI) loss, calculated by the formula: Excess BMI loss= (preoperative BMI-postoperative BMI)/ (preoperative BMI-25)

次要结局

  • Remission of diabetes mellitus(1 year after surgery)
  • Remission of dyslipidemia(1 year after surgery)

研究者

发起方
Hospital General Universitario Elche
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaime Ruiz-Tovar, MD, PhD

Head of Bariatric Surgery Unit

Hospital General Universitario Elche

相似试验